These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 19938115)
1. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115 [TBL] [Abstract][Full Text] [Related]
3. Expanding postmortem donor pool using steatotic liver grafts: a new look. Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197 [TBL] [Abstract][Full Text] [Related]
4. Use of severely steatotic grafts in liver transplantation: a matched case-control study. McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095 [TBL] [Abstract][Full Text] [Related]
6. Reliability of frozen section in the assessment of allograft steatosis in liver transplantation. Hołówko W; Mazurkiewicz M; Grąt M; Koperski L; Lewandowski Z; Smoter P; Ziarkiewicz-Wróblewska B; Górnicka B; Zborowska H; Krawczyk M Transplant Proc; 2014 Oct; 46(8):2755-7. PubMed ID: 25380910 [TBL] [Abstract][Full Text] [Related]
7. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717 [TBL] [Abstract][Full Text] [Related]
8. Use of steatotic graft in living-donor liver transplantation. Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190 [TBL] [Abstract][Full Text] [Related]
9. The optimal number of donor biopsy sites to evaluate liver histology for transplantation. Frankel WL; Tranovich JG; Salter L; Bumgardner G; Baker P Liver Transpl; 2002 Nov; 8(11):1044-50. PubMed ID: 12424718 [TBL] [Abstract][Full Text] [Related]
10. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. El-Badry AM; Breitenstein S; Jochum W; Washington K; Paradis V; Rubbia-Brandt L; Puhan MA; Slankamenac K; Graf R; Clavien PA Ann Surg; 2009 Nov; 250(5):691-7. PubMed ID: 19806055 [TBL] [Abstract][Full Text] [Related]
11. An approach to the rational use of steatotic donor livers in liver transplantation. Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794 [TBL] [Abstract][Full Text] [Related]
13. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Pine JK; Aldouri A; Young AL; Davies MH; Attia M; Toogood GJ; Pollard SG; Lodge JP; Prasad KR Liver Transpl; 2009 Sep; 15(9):1072-82. PubMed ID: 19718634 [TBL] [Abstract][Full Text] [Related]
14. Effect of graft steatosis on liver function and organ survival after liver transplantation. Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767 [TBL] [Abstract][Full Text] [Related]
15. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805 [TBL] [Abstract][Full Text] [Related]
16. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Ryan CK; Johnson LA; Germin BI; Marcos A Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149 [TBL] [Abstract][Full Text] [Related]
17. Characterization of liver enzymes on living related liver transplantation patients with acute rejection. Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785 [TBL] [Abstract][Full Text] [Related]
18. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Yersiz H; Lee C; Kaldas FM; Hong JC; Rana A; Schnickel GT; Wertheim JA; Zarrinpar A; Agopian VG; Gornbein J; Naini BV; Lassman CR; Busuttil RW; Petrowsky H Liver Transpl; 2013 Apr; 19(4):437-49. PubMed ID: 23408461 [TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? Hałoń A; Patrzałek D; Rabczyński J Transplant Proc; 2006; 38(1):193-5. PubMed ID: 16504700 [TBL] [Abstract][Full Text] [Related]
20. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]